Ann: November Presentation, page-5

Still don’t get this Company.
was 40c with 3x product lines.

major SH onboard adds 10M, most of that gone, but adds a vote of confidence.

Not much in this preso has materialized yet.
TB trials did not amount to anything.
It has abandoned Water and Sterilization

So how to value it, on lack of commercial timelines and product scope.

but has such a tight structure it can add $50M to it’s MC ( just on a director buying $10K of stock.) , with scant company updates.